MEMBER LOGIN: Your Email: Password: Remember Me
Forgot Your Password or would like to register?
JNJ Johnson & Johnson
As Of 6/19/2018 8:04:00 AM
Current Price$121.32
Current Rating4
Return Since 7/2015
Johnson & Johnson 33.31 %
S&P 50034.35 %
VFS Rating Analysis
Market ReturnAverage
return vs market
Related Links
Company News
Earnings Call Transcripts
Options Chain
Options Pricing History
For current estimates, historical performance information and more, Log in to your account.

Monthly Performance and Prediction History
Below is the monthly performance history for this security and the monthly change as compared to the stock market for this security. When a row is highlighted in green, it is identifying a stock that the model predict will outperform the portfolio for that month. When a row is highlighted in red, it is identifying a stock that the model predicted will underperform for the month. No highlight indicates the model is neutral on the stock. These predictions are always recorded at the beginning of the month, and table below shows the resulting return for the month.
DateVFS RatingPredictionRating PriceSubsequent
% Increase
Market %
Increase *
5-01-20183 $126.49-4.72%2.43%-7.15%
4-01-20182 $128.15-1.30%0.52%-1.81%
3-01-20182 $129.88-1.33%-3.13%1.80%
* As measured by the performance of the S&P 500 for the month.

JNJ15Amgen Gets FDA Nod to Add ASPIRE Data on Kyprolis Label ( 7:04:00 AM
JNJ12See what the IHS Markit Score report has to say about Johnson & Johnson. ( 5:01:00 AM
JNJ12Estimating The Fair Value Of Johnson & Johnson (NYSE:JNJ) ( 4:25:00 AM
JNJ12Growth & Income Buys | Johnson & Johnson and International Paper ( 2:38:00 PM
JNJ12Toyota, Johnson & Johnson and Hershey are the Yahoo Finance charts of the day. ( 7:57:00 AM
JNJ12J&J (JNJ) Accepts Platinum Equity's Offer for LifeScan Unit ( 7:41:00 AM
JNJ12J&J accepts $2.1 billion offer for its LifeScan unit ( 1:26:00 PM
JNJ12Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc. ( 1:01:00 PM
JNJ73 Great Stocks for Retirees to Own ( 1:04:00 PM
JNJ7After split from Actelion, Idorsia CEO plans to raise more cash in 2019 ( 7:13:00 AM
JNJ7FOCUS-After split from Actelion, Idorsia CEO plans to raise more cash in 2019 ( 6:19:00 AM
JNJ7Better Buy: Johnson & Johnson vs. Eli Lilly ( 7:06:00 AM
JNJ7Better Buy: Pfizer Inc. vs. Johnson & Johnson ( 3:31:00 AM
JNJ7Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and CVS Health ( 6:04:00 AM
JNJ7Factors of Influence in 2018, Key Indicators and Opportunity within Southwestern Energy, Johnson & Johnson, Sleep Number, QUALCOMM, Kirkland's, and Grupo Aval Acciones y Valores S.A — New Research Emphasizes Economic Growth ( 5:00:00 AM
JNJ7Toyota on the move, Johnson & Johnson shares up, Hershey under pressure ( 12:03:00 PM
JNJ7J&J Formally Accepts $2.1 Billion Offer for Diabetes Device Unit ( 1:31:00 PM
JNJ7J&J accepts $2.1 billion bid for its LifeScan diabetes business ( 1:30:00 PM
JNJ7J&J accepts $2.1 bln offer for its LifeScan unit ( 1:13:00 PM
JNJ7Johnson & Johnson accepts $2.1B deal for LifeScan business ( 1:13:00 PM
JNJ, C2Cramer floats idea for 'gloomy' ETF with Wall Street's mo... ( 3:42:00 PM
JNJ2Markets Right Now: Stocks look to recover from early skid ( 1:18:00 PM
JNJ2Why Geron Corporation Stock Is Heading Higher Today ( 5:42:00 AM
JNJ2FDA Approves the Next Generation of Customized LASIK Treatment with iDESIGN Refractive Studio ( 5:27:00 AM
JNJ2UNF, Mayo experiment with rare 3-D microscope ( 4:27:00 AM
JNJ2Big Pharma Stock Investors Beware: Another $250 Billion Patent Cliff Is Coming ( 9:03:00 AM
JNJ2LifeScan Global Corporation -- Moody's downgrades LifeScan Global's term loan B rating to B2 from B1 ( 2:01:00 PM
JNJ27 Perfect Dividend Stocks ( 8:52:00 AM
JNJ2Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III ( 7:55:00 AM
JNJ210 Best Stocks to Buy and Hold Forever ( 7:51:00 AM
JNJ2Dow 30 Stock Roundup: Caterpillar Raises Dividend, Merck's Keytruda Gets FDA Nod ( 6:25:00 AM
JNJ2Kyros Law is Investigating Claims on Behalf of Invokana users: 1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations and Heart Complications Filed. ( 5:30:00 PM
JNJ2Time Warner, Twenty-First Century Fox rise; H&R Block sinks ( 1:34:00 PM
JNJ2Deals of the day-Mergers and acquisitions ( 1:27:00 PM
JNJ, SYK2Why Dow's J&J May Try To Sweep Boston Scientific From Stryker ( 1:18:00 PM
JNJ2Lilly & AstraZeneca Scrap Studies on Alzheimer's Candidate ( 7:24:00 AM
BA, JNJ1Cramer floats idea for 'gloomy' ETF ( 3:30:00 PM
JNJ0[$$] Ever Heard of Iqvia? Its CEO Made $38 Million ( 5:13:00 PM
JNJ0[$$] Johnson & Johnson Accepts Platinum Equity's $2.1 Billion Offer for LifeScan Business ( 2:03:00 PM
JNJ-6[$$] Global pharma bleeds talent to China start-ups ( 8:55:00 PM
JNJ-6[$$] Can Investment Performance Be Predicted? ( 10:49:00 AM

WEBSITE DISCLAIMER:  Puget Investors and Vertical Financial Systems, Inc are not registered investment advisers, broker/dealers, or research analysts/organizations. The content on this website is issued solely for information purposes and should not to be construed as an offer to buy, sell, or trade in any way, any security mentioned herein.

All information presented on this website is believed to be reliable and written in good faith, but no representation or warranty, expressed or implied is made as to their accuracy, completeness or correctness. You are responsible for doing your own research before investing in any securities mentioned herein. Readers are urged to consult with their own independent financial advisors with respect to any investment. Neither Vertical Financial Systems, Inc, nor its officers or employees accept any liability whatsoever for any direct or consequential loss arising from any use of information on this website.

Past performance is not a guarantee of future performance or accuracy. Rating calculations and methodology may change at any time, and we reserve the right to make changes which may impact the accuracy of the model without prior notice to anybody.

Be advised that employees and officers of Vertical Financial Systems, Inc and may hold positions in the securities mentioned in this website.
Website Operated by Vertical Financial Systems, Inc